Developing cancer treatment applications for space: Production and purification of a monoclonal antibody
January 22, 2025
Amanda Malefyt, Ph.D., professor in the McKetta Department of Chemical and Bioprocess Engineering, secured $5,142 from the Indiana Space Grant Consortium to continue her research into cancer-targeting monoclonal antibodies.
Dr. Malefyt, a two-time INSGC grant recipient, continues to advance Trine University’s bioprocessing research capabilities by focusing on the production of cancer-targeting monoclonal antibodies.
With NASA’s priority on reducing cancer risks for astronauts, the team will optimize techniques for antibody production, testing and purification to enable future applications in microgravity.
“Receiving funding from INSGC allows us to provide increased state-of-the-art experiences for students, using current industry techniques, materials and equipment that would otherwise be outside the scope of a typical undergraduate lab budget,” commented Malefyt.
The project is broken into three main areas of focus. Junior chemical engineering (CHE) major Haylee Smith is optimizing the antibody protein production within CHO-K1 cells (Chinese hamster ovary cells modified to grow in serum-free media) and scaling up production to increase antibody yield.
“The opportunity to participate in this project gave me the ability to take my initial understanding of biological processes and learn even more,” said Smith. “I am excited about this project because of its potential impact on human life. To be able to see the work that I have accomplished and present this research with data is very rewarding.”
First-year CHE student Sudeep Iyer is completing the separation and purification process for the antibody. Senior CHE student Marshall Beebe is analyzing the binding of the purified antibodies on colorectal cancer cells, gathering data on antibody effectiveness.